DARIOHEALTH CORP (DRIO) Stock Analyst Ratings
NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to DRIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.57. This target is 480.49% above the current price.
DRIO was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about DRIO.
In the previous month the buy percentage consensus was at a similar level.
DRIO was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-01 | Stifel | Maintains | Buy -> Buy |
| 2023-08-11 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2023-07-25 | Stifel | Maintains | Buy -> Buy |
| 2023-05-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2022-11-16 | Alliance Global Partners | Maintains | Buy |
| 2022-08-18 | Aegis Capital | Maintains | Buy |
| 2022-08-16 | Cowen & Co. | Maintains | Outperform |
| 2022-05-16 | Aegis Capital | Maintains | Buy |
| 2022-05-16 | Cowen & Co. | Maintains | Outperform |
| 2022-05-13 | Alliance Global Partners | Upgrade | Neutral -> Buy |
| 2022-01-26 | Aegis Capital | Maintains | Buy |
| 2021-08-19 | Aegis Capital | Maintains | Buy |
| 2021-04-22 | Cowen & Co. | Initiate | Outperform |
| 2021-03-23 | Stifel | Initiate | Buy |
| 2021-02-08 | Aegis Capital | Maintains | Buy |